Logo of molneuroBioMed CentralBiomed Central Web Sitesearchsubmit a manuscriptregisterthis articleMolecular NeurodegenerationJournal Front Page
Mol Neurodegener. 2011; 6: 60.
Published online Aug 19, 2011. doi:  10.1186/1750-1326-6-60
PMCID: PMC3174124

Downregulation of CREB expression in Alzheimer's brain and in Aβ-treated rat hippocampal neurons

Abstract

Background

Oxidative stress plays an important role in neuronal dysfunction and neuron loss in Alzheimer's brain. Previous studies have reported downregulation of CREB-mediated transcription by oxidative stress and Aβ. The promoter for CREB itself contains cyclic AMP response elements. Therefore, we examined the expression of CREB in the hippocampal neurons of Tg2576 mice, AD post-mortem brain and in cultured rat hippocampal neurons exposed to Aβ aggregates.

Results

Laser Capture Microdissection of hippocampal neurons from Tg2576 mouse brain revealed decreases in the mRNA levels of CREB and its target, BDNF. Immunohistochemical analysis of Tg2576 mouse brain showed decreases in CREB levels in hippocampus and cortex. Markers of oxidative stress were detected in transgenic mouse brain and decreased CREB staining was observed in regions showing abundance of astrocytes. There was also an inverse correlation between SDS-extracted Aβ and CREB protein levels in Alzheimer's post-mortem hippocampal samples. The levels of CREB-regulated BDNF and BIRC3, a caspase inhibitor, decreased and the active cleaved form of caspase-9, a marker for the intrinsic pathway of apoptosis, was elevated in these samples. Exposure of rat primary hippocampal neurons to Aβ fibrils decreased CREB promoter activity. Decrease in CREB mRNA levels in Aβ-treated neurons was reversed by the antioxidant, N-acetyl cysteine. Overexpression of CREB by adenoviral transduction led to significant protection against Aβ-induced neuronal apoptosis.

Conclusions

Our findings suggest that chronic downregulation of CREB-mediated transcription results in decrease of CREB content in the hippocampal neurons of AD brain which may contribute to exacerbation of disease progression.

Keywords: Alzheimer's disease, CREB, Oxidative stress, Apoptosis, Tg2576 mice, Laser capture microdissection

Background

Cyclic AMP response element binding protein (CREB) is a constitutively expressed nuclear transcription factor that regulates the expression of genes involved in neuronal survival and function [1-3]. CREB is essential for the formation and retention of memory in several species [4,5]. CREB-mediated gene expression is increased in the hippocampus during LTP [6]. Spatial learning deficits in rats are observed after intra-hippocampal infusion of CREB antisense oligos [7]. CREB is also an important nuclear target that couples neurotrophin-mediated signaling to neuronal survival [8]. CREB undergoes phosphorylation at serine 133 in response to multiple signaling pathways [9,10]. The phosphorylated form of CREB binds to the coactivators, CREB binding protein (CBP) and p300 resulting in the facilitation of target gene expression [11]. We have reported that IGF-I induces CREB-regulated expression of the anti-apoptotic gene, bcl-2 through multiple signaling pathways [12,13].

Previous studies have reported that CREB-mediated gene expression is impaired in Alzheimer's brain. The active form of p90RSK, a critical CREB kinase, is decreased in a transgenic rat AD model [14]. Gong et al [15] reported a decrease in the levels of phosphorylated CREB in hippocampal neurons of PS1/APP double mutant transgenic mice. Treatment of these mice with rolipram, a phosphodiesterase inhibitor that increases CREB phosphorylation results in a significant improvement in cognitive function. In AD post-mortem brain, there is a decrease in the levels of CREB-regulated BDNF [16]. In cultured neurons, Aβ interferes with CREB activation by cAMP and BDNF [17-19]. However, paradoxical CREB activation in conditions associated with AD is also reported [20,21]. We demonstrated that lipid peroxidation products increase the levels of active phosphorylated form of CREB without a parallel increase in CREB-mediated gene expression [22]. We also reported oxidative stress-induced downregulation of CREB-dependent bcl-2 expression in cultured rat hippocampal neurons [23]. In the same study, we showed that hydrogen peroxide decreases CREB protein levels in neurons which were normalized by preincubation with the antioxidant, N acetyl cysteine. The objective of the present study was to determine the expression of CREB in three different models of AD, namely the Tg2576 mouse which expresses human APP with the Swedish mutation, AD post-mortem brain and cultured rat hippocampal neurons exposed to Aβ.

Results

Laser capture microdissection (LCM) reveals decrease of CREB mRNA in hippocampal neurons of Tg2576 mouse brain

CREB, a constitutively expressed nuclear transcription factor, is activated by phosphorylation at serine 133. We have previously reported that CREB expression itself is downregulated in cultured rat hippocampal neurons exposed to hydrogen peroxide [23]. The objective of the current study was to determine if oxidative stress generated in vivo in Tg2576 mouse brain decreases CREB expression. As hippocampus consists of neuronal as well as glial cells, LCM was performed to determine the expression of CREB specifically in hippocampal neurons (Figure (Figure1A).1A). Following amplification of RNA isolated from captured hippocampal neurons, the mRNA levels of CREB and its target BDNF were determined by real time RT-PCR analysis using Taqman probes. There was a 33% decrease in the mRNA levels of CREB in hippocampal neurons of Alzheimer's mouse brain (Figure (Figure1B).1B). Similarly, 38% decrease in the expression of BDNF was also observed (Figure (Figure1C).1C). The promoter for BDNF contains cyclic AMP response elements and is positively regulated by CREB.

Figure 1
Laser capture microdissection (LCM) of hippocampal neurons from Tg2576 mouse brain. Brain sections (10 μM) from Tg2576 transgenic mice along with nontransgenic controls were stained using HistoGene™ Stain, (Arcturus) to identify the neurons. ...

Decrease in CREB protein levels of Alzheimer's mouse hippocampal neurons

Western blot analysis of CREB and correction of band intensities with β actin levels showed 40% decrease (p < 0.01) in Tg2576 mouse hippocampus as compared to control samples (Figure (Figure2A2A and and2B).2B). The levels of synaptophysin, a neuronal protein, did not change significantly between the two groups. When CREB intensities were corrected for synaptophysin levels significant decrease (p < 0.01) was observed. Immunohistochemical staining of brain sections for CREB revealed gradual decrease (p < 0.05) in CREB protein with aging from 9 to 19 months in both groups of mice. More pronounced decreases were observed in all the age groups of Tg2576 mice. The images for the dentate gyrus region alone are presented (Figure (Figure2C).2C). Quantitation of CREB signals in hippocampal neurons by ImagePro analysis revealed 23-32% decrease of CREB levels in Tg2576 mouse hippocampal neurons at 9, 15, and 19 months of age when compared to nontransgenic mice at respective ages (Figure (Figure2C).2C). These findings further confirmed that CREB expression is decreased in the hippocampal neurons of Alzheimer's mouse brain and suggested the roles of Aβ deposition and aging.

Figure 2
CREB protein levels in hippocampal neurons of mouse brain. (A) Western blot analyses of CREB and synaptophysin were carried out with mouse hippocampal samples from 15-19 month old nontransgenic (Ntg) and Tg2576 mice. The blots were reprobed for β ...

Markers of oxidative stress in Tg2576 mouse brain

Oxidative stress could be one of the potential causes of decreased CREB expression observed in Alzheimer's mouse brain. We have previously reported that CREB expression is decreased in cultured rat hippocampal neurons exposed to hydrogen peroxide which is prevented when the neurons are pretreated with the antioxidant, N-acetyl cysteine [23]. Therefore, we examined the mouse brain samples for the presence of markers of oxidative stress. Aβ deposition is known to generate free radicals in AD brain resulting in lipid peroxidation. One such unsaturated aldehyde is 4-hydroxynonenal (HNE). Increased staining for HNE was seen in the regions of Aβ deposition in Tg2576 mouse brain (Figure (Figure3A).3A). Protein bound HNE levels also increased in these samples as shown by increases in the intensities of multiple bands in the Western blot analysis (Figure (Figure3B).3B). Dual immunohistochemical analysis showed colocalization of malondialdehyde (MDA), another marker for oxidative stress, stained with DAB (arrows) around NovaRed-stained Aβ deposits (Figure (Figure3C).3C). Astrocytosis as seen in AD is also likely to contribute to the generation of oxidative stress through cytokine release [24]. Therefore, mouse brain sections were double-immunostained for GFAP, a marker for astrocyte with NovaRed and for MDA with DAB (Figure (Figure3D).3D). Increase in MDA levels were seen around astrocytes as shown with a representative image. These observations suggest a pro-oxidative environment in AD brain that is likely to cause CREB downregulation. Next, double immunostaining for GFAP (astrocyte) and CREB was carried out and a representative image is shown in Figure Figure3E.3E. Decreases in CREB content were associated with abundance of GFAP in Tg2576 mouse brain. ImagePro analysis of CREB content in multiple fields further showed a mean decrease of 42% (p < 0.001) in high GFAP areas of Tg2576 mouse cortex as compared to low GFAP areas in nontransgenic mouse brain. These observations suggest a potential relationship between oxidative stress and CREB downregulation.

Figure 3
Markers of oxidative stress in Alzheimer's mouse brain. (A) Brain sections of 15-17 month old nontransgenic (Ntg) and Tg2576 mice were immunostained for HNE with NovaRED and counterstained with methyl green. (B) Western blot analysis of mouse brain samples ...

Inverse correlation between Aβ deposition and CREB content

Having observed downregulation of CREB expression in Tg2576 mouse brain, next we examined AD post-mortem samples to determine the levels of CREB. Western blot analysis showed decrease of CREB content in AD hippocampal samples when compared to age-matched controls (Figure (Figure4A).4A). Phosphorylated form of CREB also decreased significantly in AD brain which is likely to be the result of decrease in the levels of CREB protein itself. Quantitation of band intensities revealed a 52% decrease in CREB levels in AD hippocampi (Figure (Figure4B).4B). We also determined the levels of Aβ (1-42) in the post-mortem samples using a sandwich ELISA. There was a 257% increase in the levels of soluble Aβ in AD hippocampal samples (Figure (Figure4C).4C). In the case of SDS-extractable Aβ (1-42), the increase was significantly more (505%; Figure Figure4D).4D). When SDS-soluble Aβ levels were plotted against CREB band intensities, significant (p < 0.001) inverse relationship between the two was observed with a correlation co-efficient of 0.78 (Figure (Figure4E)4E) suggesting that Aβ deposition may lead to decrease in CREB content in AD brain. No significant correlation between soluble Aβ and CREB levels was observed (results not shown).

Figure 4
Decrease in CREB protein in AD-postmortem brain. (A) Post-mortem hippocampal samples (12 each) of AD cases and age-matched controls with equal protein content were electrophoresed, transferred, and immunoprobed with antibodies to CREB, phospho CREB (PCREB) ...

Decreased expression of CREB-regulated proteins and markers of oxidative stress in AD brain

Next we examined the expression of a panel of CREB-dependent proteins that are involved in neuronal function and survival. Significant decreases in AD brain were observed for BDNF (31%; p < 0.01), Bcl-2 (23%; p < 0.05), BIRC3 (44% p < 0.01) and BIRC4 (32%; p < 0.01) when compared to age-matched controls (Figure (Figure5).5). Bcl-2 is an anti-apoptotic protein that maintains the integrity of mitochondrial membrane. BIRC3 (c-IAP2) and BIRC4 (XIAP) are caspase inhibitors that play important roles in neuronal survival. In addition, the levels of proapoptotic Bax increased by 38% (p < 0.05), probably as a result of oxidative stress. Modulation of proteins in apoptosis pathway, together, resulted in 150% increase in the levels of active cleaved form of caspase-9, a marker for the intrinsic pathway of apoptosis. Markers of oxidative stress were also examined with post mortem samples. Increases in the levels GFAP (astrocyte) and protein-bound HNE were observed in AD brain (Figure (Figure6A).6A). Furthermore, Oxyblot analysis showed increases in the intensities of multiple bands (Figure (Figure6B)6B) suggesting accumulation of oxidized proteins in AD brain.

Figure 5
Markers of CREB function and apoptosis in AD-post mortem brain. Post-mortem hippocampal samples (8 each) of AD cases and age-matched controls with equal protein content were electrophoresed, transferred, and immunoprobed with antibodies for markers of ...
Figure 6
Markers of oxidative stress in AD-post mortem brain. (A) Post-mortem hippocampal samples (8 each) of AD cases and age-matched controls with equal protein content were immunoblotted for GFAP and HNE, markers of oxidative stress. Representative images are ...

Aβ-induced decrease in CREB expression in cultured rat hippocampal neurons

Although there was correlation between accumulation of oxidative stress markers and decrease of CREB content in Tg2576 mouse brain and AD post-mortem brain, these findings do not suggest a causal relationship between the two. Therefore, we used cultured rat hippocampal neurons to determine the effects of Aβ aggregates on CREB expression. Preincubation of neurons with Aβ fibrils resulted in 40-50% decrease in the activity of CREB-responsive BDNF promoter (p < 0.01) (Figure (Figure7A)7A) and CREB-promoter (p < 0.05) (Figure (Figure7B).7B). Although oligomers decreased BDNF promoter activity (p < 0.05), it had no effect on CREB promoter. Exposure of hippocampal neurons to Aβ fibrils led to generation of reactive oxygen species as shown by the fluorescence of oxidation-sensitive dye (Figure (Figure7C).7C). Aβ treatment also caused 40% decrease (p < 0.01) in CREB mRNA levels and pretreatment with the antioxidant NAC prevented this decrease (Figure (Figure7D).7D). Similar findings were obtained for CREB protein as shown by the Western blot analysis (Figure (Figure7E).7E). The promoter for CREB itself contains CRE sites. Therefore persistent decrease in CREB activity by Aβ fibril-generated oxidative stress could lead to decrease of CREB content itself. To determine if oxidative stress plays a role in Aβ-induced neuronal apoptosis, the antioxidant enzyme MnSOD was overexpressed in rat hippocampal neurons. A chimeric gene consisting of MnSOD and GFP was used in the transfection to identify the neurons expressing this enzyme. The neurons expressing MnSOD were protected from Aβ as shown by significant absence of active caspase-9 staining among GFP-expressing neurons (Figure (Figure7F7F).

Figure 7
Effects of Aβ oligomers and fibrils on CREB expression in cultured rat hippocampal neurons. (A, B) Hippocampal neurons were transfected with luciferase reporters linked to a BDNF promoter (A) or a CREB promoter (B) with LipofectAMINE 2000 reagent. ...

CREB-mediated protection of rat hippocampal neurons from Aβ-induced apoptosis

To test our hypothesis that CREB is a neuroprotective factor, we tested Aβ toxicity in rat hippocampal neurons following modulation of CREB function by plasmid transfection. The wild-type or dominant negative mutant forms of CREB were introduced into cultured neurons along with GFP (to identify the transfected cells; Figure Figure8A).8A). The transfected neurons were then exposed to Aβ fibrils and apoptotic cells were counted among green cells (Figure (Figure8B).8B). GFP expression did not affect apoptosis induced by Aβ fibrils because nuclear condensation was observed randomly among neurons with and without GFP. Counting of ~500 GFP-expressing neurons showed 64% decrease in apoptotic cells when wild-type CREB was overexpressed. In the case of neurons expressing dominant negative mutant forms of CREB, Aβ-induced neuronal death was exacerbated by 81% (KCREB) and 89% (MCREB). The gene transfer efficiency was moderate (25%-35%) by plasmid transfection in this experiment. Even though we used GFP to identify transfected cells, we sought a more efficient gene transfer method. We used adenoviral gene delivery system to modulate CREB function more efficiently in neurons. First, we tested the efficiency of gene transfer in hippocampal neurons. CREB staining was significantly higher in neurons transduced with adenoviral wild-type CREB (Figure (Figure8C).8C). Western blot analysis showed a 3-fold increase in CREB levels (Figure (Figure8D).8D). Next, the neurons transduced with adenoviral β gal (control) CREB, KCREB and MCREB were exposed to Aβ fibrils and the activity of caspase-9, a marker for the intrinsic mitochondrial pathway of apoptosis was determined (Figure (Figure8E).8E). Adenoviral β gal did not significantly increase the basal caspase-9 activity seen in neurons that were not transduced with a viral vector. Transduction of neurons with wild type CREB resulted in 42% decrease in caspase-9 activity whereas downregulation with two mutant forms of CREB resulted in exaggeration of caspase-9 activation by 140-170%. These observations suggest that the preservation of CREB function is essential to protect hippocampal neurons from Aβ-induced injury.

Figure 8
Neuroprotective effects of CREB. (A) Rat primary hippocampal neurons cultured on cover slips were transfected with green fluorescent protein (GFP) alone or in combination with wild type CREB or its mutants (KCREB or MCREB). The transfected neurons were ...

Discussion

CREB is a constitutively expressed nuclear transcription factor needed for cognition and neuronal survival. Its regulation is primarily through phosphorylation at serine 133 by several signaling kinases and thus responds to a variety of extracellular signals [10,13,25,26]. CREB-regulated gene expression has been shown to be downregulated in AD brain. In this study, we show that the expression of CREB itself is decreased in Tg2576 mouse hippocampal neurons, AD post-mortem hippocampal samples and in Aβ-treated rat hippocampal neurons. Our findings suggest that persistent downregulation of CREB-regulated gene expression could lead to decrease in the levels of CREB itself which could exacerbate neurodegeneration in AD.

Tg2576 mice overexpressing human APP with the Swedish mutation are characterized by Aβ deposition and cognitive dysfunction [27,28]. Previous studies have suggested that markers of CREB function are downregulated in the hippocampal neurons of this mouse model [14,15,29]. We demonstrate in the present study by laser capture microdissection (LCM) that the levels of CREB mRNA are significantly decreased in the hippocampal neurons of Tg2576 mouse brain (Figure (Figure1).1). The expression of BDNF, a target gene of CREB was also found to be reduced in LCM-captured neurons. Further examination of CREB protein by immunohistochemical analysis showed age-dependent decreases in hippocampal neurons, more significantly in the transgenic mouse brain (Figure (Figure2).2). Markers of oxidative stress including HNE and MDA were also elevated. We observed decreases in CREB levels especially in the regions where astrocytes were abundantly present (Figure (Figure3E).3E). Astrocytosis is known to play a role in neurodegeneration through release of cytokines [30,31]. We have previously reported in cultured MIN6 cells, a mouse pancreatic cell line that a combination of proinflammatory cytokines, IL-1β, TNF-α and IFN-γ decreases CREB expression following chronic exposure [32].

Oxidative stress is known to play an important role in the neurodegenerative process of Alzheimer's brain. Accumulation of free radicals is an important feature of aging, which is also a risk factor for AD. Markers of oxidative stress are found in aged rats, especially in those with impaired spatial learning [33]. Hensley et al. demonstrated that Aβ aggregation leads to generation of oxidative stress in vitro [34,35]. In addition, several other agents, including iron, aluminum, and advanced glycosylation end products, induce oxidative stress in AD [36-38]. Lipid peroxidation and DNA oxidation products accumulate in AD brains as a result of oxidative stress [36,39-41]. We observed increased protein-bound HNE and protein oxidation in AD post-mortem samples as shown by Oxyblot analysis (Figure (Figure6).6). SDS-extractable Aβ accumulation showed inverse correlation with CREB levels in AD post-mortem brain (Figure (Figure4E).4E). These findings suggest that Aβ-generated oxidative stress could play a role in downregulation of CREB expression. To determine the direct effects of Aβ on CREB expression we examined the activity of a luciferase reporter gene driven by the CREB promoter in cultured rat hippocampal neurons. CREB promoter activity was downregulated by Aβ fibrils but not by Aβ oligomers (Figure (Figure7B).7B). The oligomers did decrease the activity of CREB-dependent BDNF promoter activity (Figure (Figure7A).7A). Furthermore, Aβ fibril-induced decrease in CREB mRNA levels was prevented by preincubation of neurons with the antioxidant, NAC (Figure (Figure7D).7D). Thus our findings with cultured hippocampal neurons provide direct evidence for the downregulation of CREB expression by oxidative stress. Although Aβ oligomers did not play a role in the downregulation of CREB expression in this study, their role in AD pathology is well characterized.

Several reports have shown that caspase activation, a marker of apoptosis, is observed in the neurons in AD brain (reviewed in [42]). Caspase activation can also play a role in AD pathology independent of causing neuronal death. For example, caspase-cleaved tau undergoes conformational changes that facilitate filament formation, and Aβ localizes to cleaved tau [43]. Although significant loss of neurons is observed in human AD brain, marked neuronal apoptosis is not observed in mouse models of AD. We observed modulation of several proteins in the apoptosis pathway in AD post-mortem brain (Figure (Figure5).5). The levels of anti-apoptotic Bcl-2 and caspase inhibitors, BIRC3 and BIRC4 decreased and proapoptotic Bax increased in AD brain leading to activation of caspase-9, a marker for the intrinsic pathway of apoptosis. CREB plays an important role in increasing the levels of proteins that maintain mitochondrial membrane integrity and prevent the release of cytochrome c, an activator of caspase-9. Oxidative stress is known to induce neuronal apoptosis by a dual mechanism of downregulation of anti-apoptotic genes and upregulation of proapoptotic genes [44].

We have previously reported that IGF-I induces CREB-mediated bcl-2 expression in PC12 cells through multiple signaling pathways [12,13]. We also reported that oxidative stress downregulates bcl-2 expression in rat hippocampal neurons [23]. In the present study, we observed that Aβ-induced neuronal apoptosis is exaggerated when dominant negative mutant forms of CREB (KCREB and MCREB) were overexpressed along with GFP by plasmid transfection (Figure (Figure8A).8A). KCREB is mutated at the DNA binding region of CREB. This mutant will heterodimerize with endogenous CREB and sequester it away from target promoters. MCREB is mutated at the critical phosphorylation site (S133A). MCREB will bind to CRE but cannot bind to the coactivators. We also tested the effects of modulation of CREB function by adenoviral transduction on Aβ toxicity (Figure (Figure8E).8E). Apoptosis by the intrinsic pathway was induced by Aβ as shown by the activation of caspase-9 as observed in AD post-mortem brain (Figure (Figure5).5). Expression of wild type CREB decreased neuronal death induced by Aβ significantly. There was also exacerbation of Aβ-induced apoptosis when the neurons were transduced with adenoviral KCREB or MCREB. Thus chronic CREB downregulation caused by oxidative stress could be an important cause of loss of neurons in AD brain.

Conclusions

The primary events occurring in the pathogenesis of AD include the deposition of Aβ-containing senile plaques and the formation of neurofibrillary tangles. This triggers a slow neurodegenerative process involving multiple insults to neurons, including free radical generation and inflammatory responses. During this slow progressive phase, the cellular defense mechanism fails, due to oxidative stress-induced changes in transcriptional events including downregulation of CREB expression. In the treatment of AD, downstream interventions cannot be discounted as it is essential to repair neuronal injury while attempting to help clear Aβ accumulation. Small molecule enhancers of CREB-mediated gene expression are being considered as potential therapeutic agents in the treatment of AD [45].

Methods

Materials

Cell culture media and supplies were purchased from Gemini BioProducts (Woodland, CA, USA) and Invitrogen-Life Technologies (Carlsbad, CA). Antibodies to CREB, phosphorylated form of CREB, synaptophysin, BIRC3, BIRC4, Bax, active caspase-9, GFAP, and β actin were from Cell signaling (Beverly, MA). The antibodies to HNE and MDA and caspase-9 assay kit were obtained from Millipore (Billerica MA). The cDNA encoding a chimeric protein for GFP and MnSOD was provided by Dr. Sonia Flores (University of Colorado, Aurora, CO). IgG linked to Cy3 or FITC were obtained from Jackson ImmunoResearch (West Grove, PA, USA). All other fine chemicals were from Sigma (St. Louis, MO). We obtained 24 post-mortem samples (12 each of control and AD) from the AD Brain bank at University of Colorado. The mean age was 75 y for AD and 73 y for controls. The postmortem delay (PMD) was 3-12 h (mean 7 h). This is comparable to PMD reported in other studies [46-49]. The groups of subjects were characterized as AD or normal controls using the criteria from the Consortium to Establish a Registry for AD [50].

Laser capture microdissection of mouse hippocampal neurons

All animal procedures were performed with the approval of the Subcommittees on Research Safety and Institutional Animal Care and Use at the Denver Department of Veterans Affairs Medical Center, Eastern Colorado Health Care System (ACORP# 08006M). Tg2576 mice and nontransgenic controls were anesthetized and perfused with cold RNase-free phosphate buffered saline. The brain was removed and embedded in Tissue-TeK OCT in a plastic mold and frozen. Frozen brain sections (10 μM) were cut on a cryostat and collected on Superfrost slides (Fischer Scientific, Pittsburgh, PA). DEPC-treated water was used in all procedures. All solutions except wash buffers contained 0.5 U/μl RNase inhibitor. Brain sections (10 μM) were stained using HistoGene™ Stain, (Arcturus) to identify the neurons. LCM was performed using AutoPix LCM system from Arcturus Engineering (Mountain View, CA). The neurons in CA1, CA3 and dentate gyrus regions were selectively captured from each section onto Capsure LCM macro caps. Total RNA was isolated from LCM samples using a PicoPure RNA isolation kit (Arcturus). Because the RNA yield is low, additional amplification steps were used following the RiboAMP RNA amplification kit instructions from Arcturus. Real time RT-PCR analysis using Taqman probes was performed for mouse neurofilament heavy chain (mNFHc) to determine the neuronal nature of the samples and human APP to differentiate the RNA samples isolated from nontransgenic and APP transgenic mice. In addition, the mRNA levels of CREB and BDNF were compared in amplified RNA samples from nontransgenic and transgenic mice. The PCR reactions in 96 wells were monitored in real time in an ABI Prism 7700 sequence detector (Perkin Elmer Corp./Applied Biosystems).

Immunohistochemical analysis of Tg2576 mouse brain

The tissue sections were de-paraffinized and hydrated through serial dilutions of ethanol and then in distilled water. The hydrated sections were steamed in 10 mM sodium citrate buffer (pH 6.0) for 30 min for antigen retrieval. They were treated with 1% hydrogen peroxide for 10 min and blocked with 5% horse serum for 1 h at RT. Subsequently, depending on whether the antibody was from mouse or rabbit, we used a 'mouse on mouse' or rabbit ABC elite kit from Vector laboratories (Burlingame, CA), respectively. The chromogens were Novared and/or DAB. Counterstaining was with methyl green. For double immunostaining, color was developed with the first primary antibody followed by incubation with the second antibody and color development.

Western blot analysis

Proteins were resolved by SDS-PAGE electrophoresis, transferred to polyvinylidene difluoride membranes and blocked with 5% non-fat dry milk for 1 h at RT. The membranes were exposed to primary antibodies at a dilution of 1:1000 overnight at 4°C. After washing with 5% non-fat milk, the membranes were incubated in the presence of appropriate secondary antibodies linked to alkaline phosphatase for 1 h at RT. After treating with alkaline washing buffer (10 mM Tris-HCl (pH 9.5), 10 mM NaCl and 1 mM MgCl2), signals were developed with CDP-Star reagent (New England Biolabs, Beverly, MA) and exposed to X-ray film. The intensity of bands were measured by using Fluor-S MultiImager and Quantity One software (Bio-Rad, Hercules, CA) and corrected for the levels of β actin. Oxyblot analysis: Oxidative modification of proteins by free radicals was determined for AD-post mortem samples along with age-matched controls using a kit from Millipore (Billerica, MA). The protein samples (20 μg) in 5 μl were mixed with 5 μl of 12% SDS for a final concentration of 6% and derivatized with 10 μl of 1X DNPH solution. The samples were incubated at RT for 15 min, neutralized and electrophoresed. Following transfer, the blots were immunoprobed with anti-DNP antibody and the signals were developed with CDP-Star.

Aβ assay and preparation of Aβ aggregates

After extracting the soluble fractions from post-mortem samples with Tris-buffered saline (pH 7.6) containing 1% Triton X-100 and protease inhibitors, the tissue pellets were extracted with 2% SDS containing protease inhibitors. The extracts were appropriately diluted and Aβ 1-42 levels were determined by sandwich ELISA. For capture, the Ban-50 (1-42) antibody was used and the BC-05 antibody was used for detection. To determine Aβ-induced toxicity in cultured neurons, Aβ aggregates were prepared by the following procedure: Aβ (1-42) peptide purchased from Peptide 2.0 (Chantilly, VA) was first monomerized by resuspending in hexafluoroisopropanol followed by incubation at RT for 1 h. After evaporation of solvent under vacuum, Aβ is dissolved in DMSO and stored at -20°C. Aβ oligomer stock (100 μM) was prepared by incubation in F-12 (without phenol red) culture medium at 4°C for 24 h. Aβ fibril stock (100 μM) was prepared by incubation in HCl (10 mM) at 37°C for 24 h.

Culture of rat hippocampal neurons and transfection

Hippocampal neurons were isolated from E18 rat embryos obtained from timed-pregnant Sprague-Dawley rats as previously described [51]. The astrocyte population was less than 5%. The neurons were cultured in serum-free Eagle's medium containing 2% antioxidant-free B27 supplement (Life Technologies). The experiments were carried out in these neurons after one week in culture [22]. Total RNA was isolated from treated neurons using an isolation kit (Versagene RNA; Fisher Scientific, Pittsburgh, PA). Transient transfection of rat hippocampal neurons cultured in 12 well dishes to about 70% confluence was performed using LipofectAMINE 2000 reagent (Invitrogen-Life Technologies) according to the procedure described previously [22]. BDNF promoter and CREB promoter linked to a luciferase reporter gene were provided by Anne West (Harvard Medical School, Boston) and Dr. Dwight Klemm (University of Colorado) respectively. A constitutively active renilla luciferase (pRL-TK-luc) was included to correct for transfection efficiency and nonspecific actions of oxidative stress. After 6 h of transfection, the neurons were exposed to Aβ oligomers or fibrils for 18 h. The cells were processed for the assay of luciferases using dual luciferase assay kit (Promega). The transfection efficiency for rat hippocampal neurons using LipofectAMINE 2000 reagent was ~30%.

Immunocytochemistry

Rat hippocampal neurons were cultured on glass cover slips (Carolina Biological Supply, Burlington, NC) prepared according to the methods of Goslin and Banker [52]. Treated neurons were fixed in 4% paraformaldehyde for 30 min at RT and washed with PBS. The cells were permeabilized in PBS containing 0.2% Triton X-100 and 5% BSA for 90 min at RT, followed by incubation with the primary antibody at 4°C overnight. Double immunostaining was performed using monoclonal and polyclonal antibodies for two targets. After washing with PBS, appropriate secondary antibodies linked to Cy3 and FITC were added along with DAPI (2 μg/ml; nuclear staining) for 90 min at RT. The cells were then washed in PBS, mounted on slides and examined by digital deconvolution microscopy.

Measurement of intracellular oxidative stress

Intracellular ROS (reactive oxygen species) generation was measured in neurons exposed to Aβ aggregates using an oxidation-sensitive dye, 5- (and 6-)chloromethyl-2',-7'-dichlorodihydrofluorescein diacetate (CM-H2DCFDA). When the cells are loaded with this dye, its acetate groups are cleaved by cellular nonspecific esterases, trapping the dye in the cell. Although this "leuco" form of the dye is colorless, the oxidized dye fluoresces at 535 nm when excited with 485 nm light. The cells were loaded with the dye and the fluorescence was measured using the CytoFluor multiwell plate reader.

Caspase-9 assay

Cultured rat hippocampal neurons transduced with adenoviruses followed by exposure to Aβ fibrils were processed for the assay of caspase-9 using a kit from Millipore (Billerica, MA). Supernatant of the cell lysates were incubated in the presence of substrate, p-nitroanilide-labeled LEHD. The released chromophore was read at 405 nm using a microplate reader.

Statistical analysis

Data presented are Mean ± SE. Statistical evaluation was performed by one-way ANOVA with Dunnett's multiple comparison test.

Abbreviations

AD: Alzheimer's disease; AMP: Adenosine monophosphate; BDNF: Brain-derived neurotrophic factor; CBP: CREB binding protein; CREB: Cyclic AMP response element binding protein; GFP: Green fluorescent protein; HNE: 4-hydroxynonenal; IGF-I: Insulin-like growth factor-I; LCM: Laser capture microdissection; MDA: Malone dialdehyde; NAC: N-acetyl cysteine; RT-PCR: Reverse transcription-polymerase chain reaction

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

SP designed the experiments, performed the laser capture microdissection and wrote the manuscript. MW performed immunohistochemical analysis and experiments with cultured rat hippocampal neurons. TM performed Western blot analysis and contributed in other experimental procedures. CIS provided the AD post-mortem brain samples. CBE was a consultant for experiments with Tg2576 mouse brain. All authors have read and approved the final manuscript.

Acknowledgements

This work was carried out with the use of resources and facilities at Denver VA Medical Center. This study was supported by Merit Review grant NEUD-004-07F from the Veterans Administration (S.P.).

References

  • Benito E, Barco A. CREB's control of intrinsic and synaptic plasticity: implications for CREB-dependent memory models. Trends Neurosci. pp. 230–240. [PubMed]
  • Sakamoto K, Karelina K, Obrietan K. CREB: a multifaceted regulator of neuronal plasticity and protection. J Neurochem. pp. 1–9. [PMC free article] [PubMed]
  • Lonze BE, Ginty DD. Function and regulation of CREB family transcription factors in the nervous system. Neuron. 2002;35:605–623. doi: 10.1016/S0896-6273(02)00828-0. [PubMed] [Cross Ref]
  • Impey S, Smith DM, Obrietan K, Donahue R, Wade C, Storm DR. Stimulation of cAMP response element (CRE)-mediated transcription during contextual learning. Nat Neurosci. 1998;1:595–601. doi: 10.1038/2830. [PubMed] [Cross Ref]
  • Frank DA, Greenberg ME. CREB: a mediator of long-term memory from mollusks to mammals. Cell. 1994;79:5–8. doi: 10.1016/0092-8674(94)90394-8. [PubMed] [Cross Ref]
  • Impey S, Mark M, Villacres EC, Poster S, Chavkin C, Storm DR. Induction of CRE-mediated gene expression by stimuli that generate long-lasting LTP in area CA1 of the hippocampus. Neuron. 1996;16:973–982. doi: 10.1016/S0896-6273(00)80120-8. [PubMed] [Cross Ref]
  • Guzowski JF, McGaugh JL. Antisense oligodeoxynucleotide-mediated disruption of hippocampal cAMP response element binding protein levels impairs consolidation of memory for water maze training. Proc Natl Acad Sci USA. 1997;94:2693–2698. doi: 10.1073/pnas.94.6.2693. [PMC free article] [PubMed] [Cross Ref]
  • Finkbeiner S. CREB couples neurotrophin signals to survival messages. Neuron. 2000;25:11–14. doi: 10.1016/S0896-6273(00)80866-1. [PubMed] [Cross Ref]
  • Shaywitz AJ, Greenberg ME. CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem. 1999;68:821–861. doi: 10.1146/annurev.biochem.68.1.821. [PubMed] [Cross Ref]
  • Pugazhenthi S, Boras T, O'Connor D, Meintzer MK, Heidenreich KA, Reusch JE. Insulin-like growth factor I-mediated activation of the transcription factor cAMP response element-binding protein in PC12 cells. Involvement of p38 mitogen-activated protein kinase-mediated pathway. J Biol Chem. 1999;274:2829–2837. doi: 10.1074/jbc.274.5.2829. [PubMed] [Cross Ref]
  • Kwok RPS, Lundblad JR, Chrivia JC, Richards JP, Bächlinger HP, Brennan RG, Roberts SGE, Green MR, Goodman RH. Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature. 1994;370:223–229. doi: 10.1038/370223a0. [PubMed] [Cross Ref]
  • Pugazhenthi S, Miller E, Sable C, Young P, Heidenreich KA, Boxer LM, Reusch JE-B. Insulin-like growth factor-I induces bcl-2 promoter through the transcription factor cAMP-response element binding protein. J Biol Chem. 1999;274:27529–27535. doi: 10.1074/jbc.274.39.27529. [PubMed] [Cross Ref]
  • Pugazhenthi S, Nesterova A, Sable C, Heidenreich K, Boxer L, Heasley L, Reusch J. Akt/Protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein. J Biol Chem. 2000;275:10761–10766. doi: 10.1074/jbc.275.15.10761. [PubMed] [Cross Ref]
  • Echeverria V, Ducatenzeiler A, Dowd E, Janne J, Grant SM, Szyf M, Wandosell F, Avila J, Grimm H, Dunnett SB. et al. Altered mitogen-activated protein kinase signaling, tau hyperphosphorylation and mild spatial learning dysfunction in transgenic rats expressing the beta-amyloid peptide intracellularly in hippocampal and cortical neurons. Neuroscience. 2004;129:583–592. doi: 10.1016/j.neuroscience.2004.07.036. [PubMed] [Cross Ref]
  • Gong B, Vitolo OV, Trinchese F, Liu S, Shelanski M, Arancio O. Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment. J Clin Invest. 2004;114:1624–1634. [PMC free article] [PubMed]
  • Phillips HS, Hains JM, Armanini M, Laramee GR, Johnson SA, Winslow JW. BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease. Neuron. 1991;7:695–702. doi: 10.1016/0896-6273(91)90273-3. [PubMed] [Cross Ref]
  • Vitolo OV, Sant'Angelo A, Costanzo V, Battaglia F, Arancio O, Shelanski M. Amyloid beta -peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling. Proc Natl Acad Sci USA. 2002;99:13217–13221. doi: 10.1073/pnas.172504199. [PMC free article] [PubMed] [Cross Ref]
  • Tong L, Thornton PL, Balazs R, Cotman CW. Beta-amyloid-(1-42) impairs activity-dependent cAMP response element-binding protein signaling in neurons at concentrations in which cell is not compromised. J Biol Chem. 2001;276:17301–17306. doi: 10.1074/jbc.M010450200. [PubMed] [Cross Ref]
  • Tong L, Balazs R, Thornton PL, Cotman CW. Beta-amyloid peptide at sublethal concentrations downregulates brain-derived neurotrophic factor functions in cultured cortical neurons. J Neurosci. 2004;24:6799–6809. doi: 10.1523/JNEUROSCI.5463-03.2004. [PubMed] [Cross Ref]
  • McDonald D, Bamberger M, Combs C, Landreth G. b-Amyloid fibrils activate parallel mitogen-activated kinase pathways in microglia and THP1 monocytes. J Neurosci. 1998;18:4451–4460. [PubMed]
  • Sato N, Kamino K, Tateishi K, Satoh T, Nishiwaki Y, Yoshiiwa A, Miki T, Ogihara T. Elevated amyloid beta protein(1-40) level induces CREB phosphorylation at serine-133 via p44/42 MAP kinase (Erk1/2)-dependent pathway in rat pheochromocytoma PC12 cells. Biochem Biophys Res Commun. 1997;232:637–642. doi: 10.1006/bbrc.1997.6341. [PubMed] [Cross Ref]
  • Pugazhenthi S, Phansalkar K, Audesirk G, West A, Cabell L. Differential regulation of c-jun and CREB by acrolein and 4-hydroxynonenal. Free Radic Biol Med. 2006;40:21–34. doi: 10.1016/j.freeradbiomed.2005.08.023. [PubMed] [Cross Ref]
  • Pugazhenthi S, Nesterova A, Jambal P, Audesirk G, Kern M, Cabell L, Eves E, Rosner MR, Boxer LM, Reusch JE. Oxidative stress-mediated down-regulation of bcl-2 promoter in hippocampal neurons. J Neurochem. 2003;84:982–996. doi: 10.1046/j.1471-4159.2003.01606.x. [PubMed] [Cross Ref]
  • Takuma K, Baba A, Matsuda T. Astrocyte apoptosis: implications for neuroprotection. Prog Neurobiol. 2004;72:111–127. doi: 10.1016/j.pneurobio.2004.02.001. [PubMed] [Cross Ref]
  • Gonzalez GA, Montminty MR. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at Serine 133. Cell. 1989;59:675–680. doi: 10.1016/0092-8674(89)90013-5. [PubMed] [Cross Ref]
  • Xing J, Ginty DD, Greenberg ME. Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Science. 1996;273:959–963. doi: 10.1126/science.273.5277.959. [PubMed] [Cross Ref]
  • King DL, Arendash GW. Behavioral characterization of the Tg2576 transgenic model of Alzheimer's disease through 19 months. Physiol Behav. 2002;75:627–642. doi: 10.1016/S0031-9384(02)00639-X. [PubMed] [Cross Ref]
  • Kawarabayashi T, Younkin LH, Saido TC, Shoji M, Ashe KH, Younkin SG. Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J Neurosci. 2001;21:372–381. [PubMed]
  • Wu ZL, Ciallella JR, Flood DG, O'Kane T M, Bozyczko-Coyne D, Savage MJ. Comparative analysis of cortical gene expression in mouse models of Alzheimer's disease. Neurobiol Aging. 2005. [PubMed]
  • Wyss-Coray T. Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat Med. 2006;12:1005–1015. [PubMed]
  • Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH. Mechanisms underlying inflammation in neurodegeneration. Cell. pp. 918–934. [PMC free article] [PubMed]
  • Jambal P, Masterson S, Nesterova A, Bouchard R, Bergman B, Hutton JC, Boxer LM, Reusch JE, Pugazhenthi S. Cytokine-mediated downregulation of the transcription factor CREB in pancreatic beta -cells. J Biol Chem. 2003;278:23055–23065. doi: 10.1074/jbc.M212450200. [PubMed] [Cross Ref]
  • Nicolle MM, Gonzalez J, Sugaya K, Baskerville KA, Bryan D, Lund K, Gallagher M, McKinney M. Signatures of hippocampal oxidative stress in aged spatial learning-impaired rodents. Neuroscience. 2001;107:415–431. doi: 10.1016/S0306-4522(01)00374-8. [PubMed] [Cross Ref]
  • Hensley K, Carney JM, Mattson MP, Aksenova M, Harris M, Wu JF, Floyd RA, Butterfield DA. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer's disease. Proc Natl Acad Sci USA. 1994;91:3270–3274. doi: 10.1073/pnas.91.8.3270. [PMC free article] [PubMed] [Cross Ref]
  • Huang X, Atwood CS, Hartshorn MA, Multhaup G, Goldstein LE, Scarpa RC, Cuajungco MP, Gray DN, Lim J, Moir RD. et al. The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry. 1999;38:7609–7616. doi: 10.1021/bi990438f. [PubMed] [Cross Ref]
  • Markesbery WR. Oxidative stress hypothesis in Alzheimer's disease. Free Radical Biology & Medicine. 1997;23:134–147. doi: 10.1016/S0891-5849(96)00629-6. [PubMed] [Cross Ref]
  • Smith MA, Harris PL, Sayre LM, Perry G. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci USA. 1997;94:9866–9868. doi: 10.1073/pnas.94.18.9866. [PMC free article] [PubMed] [Cross Ref]
  • Falangola MF, Lee SP, Nixon RA, Duff K, Helpern JA. Histological co-localization of iron in Abeta plaques of PS/APP transgenic mice. Neurochem Res. 2005;30:201–205. doi: 10.1007/s11064-004-2442-x. [PMC free article] [PubMed] [Cross Ref]
  • Behl C. Amyloid beta protein toxicity and oxidative stress in Alzheimer's disease. Cell Tissue Res. 1997;290:471–480. doi: 10.1007/s004410050955. [PubMed] [Cross Ref]
  • Smith MA, Rottkamp CA, Nunomura A, Raina AK. Oxidative stress in Alzheimer's disease. Biochim Biophys Acta. 2000;1502:139–144. [PubMed]
  • Keller JN, Schmitt FA, Scheff SW, Ding Q, Chen Q, Butterfield DA, Markesbery WR. Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology. 2005;64:1152–1156. doi: 10.1212/01.WNL.0000156156.13641.BA. [PubMed] [Cross Ref]
  • Roth KA. Caspases, apoptosis, and Alzheimer disease: causation, correlation, and confusion. J Neuropathol Exp Neurol. 2001;60:829–838. [PubMed]
  • Rissman RA, Poon WW, Blurton-Jones M, Oddo S, Torp R, Vitek MP, LaFerla FM, Rohn TT, Cotman CW. Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology. J Clin Invest. 2004;114:121–130. [PMC free article] [PubMed]
  • Mattson MP. Apoptosis in neurodegenerative disorders. Nature Rev Mol Cell Biol. 2000;1:120–129. doi: 10.1038/35040009. [PubMed] [Cross Ref]
  • Xia M, Huang R, Guo V, Southall N, Cho MH, Inglese J, Austin CP, Nirenberg M. Identification of compounds that potentiate CREB signaling as possible enhancers of long-term memory. Proc Natl Acad Sci USA. 2009;106:2412–2417. doi: 10.1073/pnas.0813020106. [PMC free article] [PubMed] [Cross Ref]
  • Cummings TJ, Strum JC, Yoon LW, Szymanski MH, Hulette CM. Recovery and expression of messenger RNA from postmortem human brain tissue. Mod Pathol. 2001;14:1157–1161. doi: 10.1038/modpathol.3880451. [PubMed] [Cross Ref]
  • Loring JF, Wen X, Lee JM, Seilhamer J, Somogyi R. A gene expression profile of Alzheimer's disease. DNA Cell Biol. 2001;20:683–695. doi: 10.1089/10445490152717541. [PubMed] [Cross Ref]
  • Browning MD, Dudek EM, Rapier JL, Leonard S, Freedman R. Significant reductions in synapsin but not synaptophysin specific activity in the brains of some schizophrenics. Biol Psychiatry. 1993;34:529–535. doi: 10.1016/0006-3223(93)90195-J. [PubMed] [Cross Ref]
  • Blalock EM, Geddes JW, Chen KC, Porter NM, Markesbery WR, Landfield PW. Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc Natl Acad Sci USA. 2004;101:2173–2178. doi: 10.1073/pnas.0308512100. [PMC free article] [PubMed] [Cross Ref]
  • Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 1991;41:479–486. [PubMed]
  • Audesirk T, Audesirk G, Ferguson C, Shugarts D. Effects of inorganic lead on the differentiation and growth of cultured hippocampal and neuroblastoma cells. Neurotoxicology. 1991;12:529–538. [PubMed]
  • Goslin K, Banker G. In: Culturing Nerve cells. Banker G, Goslin K, editor. Cambridge, Massachusetts: MIT Press; 1991. Rat hippocampal neurons in low-density culture; pp. 251–281.

Articles from Molecular Neurodegeneration are provided here courtesy of BioMed Central
PubReader format: click here to try

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...